2023 Publications

Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study

British Journal of Clinical Pharmacology, Volume 89, Issue 7: Page 1911, July 2023


Authors: Tony Lockett, et al

The use of near-infrared as process analytical technology (PAT) during 3D printing tablets at the point-of-care

International Journal of Pharmaceutics, Volume 642, July 2023
Authors: Mohamed A. Alhnan, et al

Towards point-of-care manufacturing and analysis of immediate-release 3D-printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia

International Journal of Pharmaceutics, Volume 642, July 2023
Authors: Mohamed A. Alhnan, et al

A systematic review of models of patient engagement in the development and lifecycle management of medicines

Drug Discovery Today, Volume 28, Issue 9
Authors: F.I. Auwal, C. Copeland, E.J. Clark, C. Naraynassamy, G.R. McClelland

The Central Role of Ethics in Medical Affairs Practice

Pharmaceutical Medicine 37, Page 275, May 2023
Author: Carl Naraynassamy

The missing piece of the Windsor Framework: the patients

BMJ, Issue 361, Page 961, May 2023
Author: Francesca Mason

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet, Volume 401, Issue 10388, Page 1571, April 2023
Authors: Yasser Mostafa Kamel, et al

A case-control study of antipsychotic use and pneumonia-related mortality in the United Kingdom

Acta Psychiatrica Scandinavica, Volume 147, Issue 3, Page 229, Mar 2023
Authors: Caroline S Copeland, et al

Serum amyloid - A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19

Frontiers in Medicine, Volume 10, March 2023
Authors: Anthony Lockett, John Posner, et al

The use of Special-Order products in England between 2012 and 2020: An insight into the need for Point-of-Care manufacturing

International Journal of Pharmaceutics, Volume 637, February 2023
Authors: Alan Phillips, Shalini Mondal

Improving early phase oncology clinical trial design: The case for finding the optimal biological dose

Pharmaceutical Statistics, Volume 22, Issue 4, July 2023
Authors: Mohamed A Alhnan, et al

CAR-T: What Is Next?

Cancers, Issue 15, Volume 3, Page 663, January 2023
Authors: Bams Abila, et al